Partnerships
Atropos Health partners with patient-centric healthcare data company SEQSTER
The collaboration between Atropos Health and SEQSTER aims to use AI and real-world data to speed up medication development, enhance clinical judgement, and empower all patients with evidence-based treatment recommendations. Read More>>
Patientory, Inc. partners with WIVA for healthcare data solution
Patientory, Inc. will leverage WIVA’s experience to improve healthcare data accessibility. The Patientory blockchain-based platform aims to increase patient empowerment and data management by addressing fragmented healthcare data. Read More>>
Center setup expansion
Cleveland Clinic London opens outpatient clinic on opposite end of the city
The Cleveland Clinic London’s Moorgate Outpatient Centre expansion aims to provide high-quality care and quick access to London patients. Within the city’s Square Mile, it will provide a comprehensive range of medical services, including diagnostic screenings, specialist consultations, and urgent eye treatment. Read More>>
Mergers and Acquisitions
ThedaCare and Froedtert finalize merger
The merger of ThedaCare and Froedtert has been completed, resulting in a united health system. The transition will be led by Cathy Jacobson and Dr. Imran A. Andrabi, with Dr. Andrabi taking over as president and CEO after a six-month period. The united organisation intends to provide comprehensive healthcare services. Read More>>
Executive Movement
Adela appoints Precision Medicine veteran Lisa Alderson as CEO
The appointment of Lisa Alderson as CEO of Adela is intended to shepherd the company through the process of product scaling and commercialization in the healthcare industry. Ms. Alderson has over 20 years of experience in early-stage company development at the interface of technology and healthcare. Read More>>
New Product Development and Product Launch
Takeda enters into two-year contract with Canadian Blood Services for GLASSIA®, treatment for rare form of Emphysema
The goal of the GLASSIA® product launch is to give a therapy alternative for individuals with emphysema caused by a severe hereditary lack of Alpha-1 antitrypsin, increasing their quality of life and reducing disease progression. Read More>>
|